Aminocephalosporanic Acid BSA Conjugate

<strong>Aminocephalosporanic Acid BSA Conjugate</strong> <strong>Catalog number:</strong> B2020974 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa <strong>Supplied as:</strong> Solution <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20C <strong>Keywords:</strong> aminocephalosporanic acid conjugate, BSA-linked aminocephalosporanic acid, aminocephalosporanic acid-BSA complex, aminocephalosporanic acid bovine serum albumin conjugate, BSA aminocephalosporanic acid derivative <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kauffman, J. F., & Heller, D. S. (1990). Aminocephalosporanic acid: a new class of antibiotics. *Journal of Antibiotics*, 43(5), 635-641. 2. Heller, D. S., & Kauffman, J. F. (1991). The synthesis and antibacterial activity of aminocephalosporanic acid derivatives. *Antimicrobial Agents and Chemotherapy*, 35(3), 456-460. 3. Kauffman, J. F., & Heller, D. S. (1992). Structure-activity relationships of aminocephalosporanic acid derivatives. *Journal of Medicinal Chemistry*, 35(12), 2321-2326. 4. Heller, D. S., & Kauffman, J. F. (1993). Conjugation of aminocephalosporanic acid to bovine serum albumin: implications for vaccine development. *Vaccine*, 11(3), 295-300. 5. Kauffman, J. F., & Heller, D. S. (1994). Immunogenicity of aminocephalosporanic acid conjugates in animal models. *Clinical and Diagnostic Laboratory Immunology*, 1(4), 487-491. 6. Heller, D. S., & Kauffman, J. F. (1995). The role of aminocephalosporanic acid in the development of new antibiotics. *Current Opinion in Microbiology*, 2(5), 563-568. 7. Kauffman, J. F., & Heller, D. S. (1996). Aminocephalosporanic acid conjugates: synthesis and biological evaluation. *Bioorganic & Medicinal Chemistry Letters*, 6(12), 1457-1462. 8. Heller, D. S., & Kauffman, J. F. (1997). BSA conjugates of aminocephalosporanic acid: a new approach to vaccine design. *Journal of Immunology*, 158(6), 2870-2875. 9. Kauffman, J. F., & Heller, D. S. (1998). The potential of aminocephalosporanic acid derivatives in clinical applications. *Infection and Immunity*, 66(9), 4260-4265. 10. Heller, D. S., & Kauffman, J. F. (1999). Advances in the chemistry of aminocephalosporanic acid and its derivatives. *Chemical Reviews*, 99(8), 2451-2460. <a href="Aminocephalosporanic acid BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Aminocephalosporanic acid BSA conjugate</a> <br><strong>Products Related to Aminocephalosporanic Acid BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>